Dexcom G6 Continuous Glucose Monitoring System Now Covered in Manitoba for Young People With Type 1 Diabetes
- Dexcom CGM use is proven to improve glycemic control1,2and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring.3
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210929005289/en/
The Dexcom G6 CGM System is now covered by
“We are so pleased to see more and more provinces demonstrating their commitment to improving the health of people with diabetes. We know that when diabetes management is made easier through real-time CGM and data-sharing, the person living with diabetes and their entire circle of care can benefit,” says
The Dexcom G6 CGM System includes a small, wearable sensor that measures glucose just below the skin; a transmitter to send glucose levels continuously and wirelessly to a display device; and a compatible smart device* or receiver that displays real-time glucose data to users without the need for fingersticks† or scanning. The Dexcom G6 provides users with real-time alerts, including a predictive Urgent Low Soon alert, and can warn the user in advance of hypoglycemia — giving them time to take appropriate action before it occurs. With the use of the Dexcom Follow App‡, parents and caregivers can also access their loved one’s glucose levels remotely and be alerted if they are going out of their target glucose range. As part of the
“I’m thrilled to hear the news of the improved coverage for continuous glucose monitors and insulin pumps for young people in the province,” says Dr.
Earlier this month, the Diabetes Canada Clinical Practice Guidelines review committee updated its recommendations for glucose monitoring, stating that real-time CGM (rtCGM), like the Dexcom G6, should be used by individuals with type 1 diabetes treated with basal-bolus insulin injections or an insulin pump in order to reduce A1C and increase time in range, reduce duration and incidence of hypoglycemia and, in adults, improve quality of life.4
† If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
* For a list of compatible devices, please visit dexcom.com/compatibility
‡ Following requires the Dexcom Follow App and an Internet connection. Followers should always confirm readings on the Dexcom G6 App or Receiver before making diabetes treatment decisions.
1 Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The DIAMOND randomized clinical trial. JAMA 2017;317(4):371-8.
2 Welsh JB, Gao P, Derdzinski M, et al. Accuracy, Utilization, and Effectiveness Comparisons of Different Continuous Glucose Monitoring Systems. Diabetes Technol Ther 2019;21(3):128-32.
3 Roze S, Isitt J,
4 Cheng AYY, Feig DS, Ho J, et al. Blood glucose monitoring in adults and children with diabetes: update 2021.